Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00378521Phase 2Completed
Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
Raynaud's DiseaseRaynaud's Disease Secondary to Autoimmune DiseaseRaynaud's Disease Secondary to Scleroderma
Principalinvestigator

Research Network

Collaboration Network

33 collaborators·52 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Christiansen, MD

Diablo Clinical Research

Related
10 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

Abbott Diabetes Care
Collaborated on 1 trial
Similarity Score24%

Bruce Bode, MD

Atlanta Diabetes Associates

Related
8 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

Abbott Diabetes Care
Collaborated on 1 trial
Similarity Score24%

Timothy Bailey, MD

AMCR Institute

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

Abbott Diabetes Care
Collaborated on 1 trial
Similarity Score24%

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score12%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score12%

Roman Hovorka, PhD

University of Cambridge

Related
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score12%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score12%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score12%

Adrian Vella, MD

Mayo Clinic

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score12%

Mustafa H Temel, M.D.

Uskudar State Hospital

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00378521Phase 2PrincipalInvestigator

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Raynaud's DiseaseRaynaud's Disease Secondary to Autoimmune DiseaseRaynaud's Disease Secondary to Scleroderma
Completed
NCT02073058PrincipalInvestigator

Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System

Type 1 DiabetesType 2 Diabetes
Completed

All 2 trials loaded